Tularemia Recruiting Phase Trials for Aminocaproic acid (DB00513)

Also known as: Tularaemia / Yatobyo / Unspecified tularemia / Unspecified tularaemia / Francisella tularensis infection

Indication	Status	Phase
DBCOND0000421 (Tularemia)	Recruiting	Not Available

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01431326	Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care		Alfentanil (DB00802) Amikacin (DB00479) Aminocaproic acid (DB00513) Bosentan (DB00559) Cefepime (DB01413) Cidofovir (DB00369) Ciprofloxacin (DB00537) Clozapine (DB00363) Fosfomycin (DB00828) Haloperidol (DB00502) Labetalol (DB00598) Lurasidone (DB08815) Methylprednisolone (DB00959) Molindone (DB01618) Nafcillin (DB00607) Nifedipine (DB01115) Oxycodone (DB00497) Pentobarbital (DB00312) Piperacillin (DB00319) Rocuronium (DB00728) Sevelamer (DB00658) Spironolactone (DB00421) Tazobactam (DB01606) Tobramycin (DB00684) Tranexamic acid (DB00302) Vancomycin (DB00512) Vecuronium (DB01339) Warfarin (DB00682) Ziprasidone (DB00246) Zolpidem (DB00425)